Purchase of Shares by Employee Benefit Trust
Source: RNS
ELIXIRR INTERNATIONAL PLC
("Elixirr", the "Company" or the "Group")
Purchase of Shares by Employee Benefit Trust
and
Director/PDMR Shareholding
Elixirr International plc (AIM:ELIX), an established, global award-winning challenger consultancy, announces that the Elixirr International plc Employee Benefit Trust (the "EBT") purchased from certain Directors, PDMRs, employees and shareholders of the Company (the "Purchase") 1,419,890 ordinary shares in the capital of the Company ("Ordinary Shares") at a price of 565 pence per Ordinary Share.
The Purchase has been made at the instruction of Apex Group Fiduciary Services Limited as independent trustee of the EBT following a recommendation by the Board of the Company. The decision to make the Purchase is to ensure that the EBT has sufficient shares to satisfy demand including for satisfaction of options, equity for new Partners and equity for those joining the firm through acquisition. Accordingly, the Purchase will mitigate the need for dilution in the equity of the Company as it executes on its growth strategy.
Following the Purchase, the EBT's beneficial holding is 1,782,344 Ordinary Shares representing 3.8 per cent of the issued share capital of the Company.
Participation by certain Directors and PDMRs in the Purchase are outlined in the table below:
|
Director/PDMR |
Position |
Ordinary Shares Sold |
Share Sale Price |
Resultant Holding |
% of total voting rights |
|
Gavin Patterson |
Chair |
176,991 |
565p |
439,679 |
0.9% |
|
Simon Retter |
Non-Executive Director |
88,496 |
565p |
288,237 |
0.6% |
|
Ian Ferguson |
Executive Director |
176,991 |
565p |
2,417,091 |
5.1% |
|
Nicholas Willott |
Finance Director & Company Secretary |
20,000 |
565p |
254,073 |
0.5% |
|
Clare Filby |
Chief Operating Officer |
35,398 |
565p |
498,400 |
1.1% |
|
Eric Rich |
Partner |
79,651 |
565p |
592,118 |
1.3% |
|
Brandon Bichler |
Partner |
69,479 |
565p |
642,712 |
1.4% |
|
Dieter Halfar |
Partner |
44,248 |
565p |
316,461 |
0.7% |
|
Daniel Garsin |
Partner |
24,651 |
565p |
221,855 |
0.5% |
For further information please contact:
|
Elixirr International plc Stephen Newton, CEO Graham Busby, CFO
|
|
|
|||
|
Public and Investor Relations contacts: investor-relations@elixirr.com
Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker) Stephen Keys, Charlie Beeson (Corporate Finance) Sunila de Silva (Corporate Broking)
Investec Bank plc (Joint Broker) Carlton Nelson, Henry Reast (Corporate Broking) |
+44 (0) 20 7220 0500
+44 (0) 20 7597 4000 |
|
|||
|
|
|
|
|||
About Elixirr International plc
Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.
Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
|
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||||||||||||||||||||||||||
|
a) |
Name |
1. Gavin Patterson 2. Simon Retter 3. Ian Ferguson 4. Nicholas Willott 5. Clare Filby 6. Eric Rich 7. Brandon Bichler 8. Dieter Halfar 9. Daniel Garsin
|
||||||||||||||||||||||||||||||
|
2. |
Reason for the Notification |
|||||||||||||||||||||||||||||||
|
a) |
Position/status |
1. Director 2. Director 3. Director 4. PDMR 5. PDMR 6. PDMR 7. PDMR 8. PDMR 9. PDMR |
||||||||||||||||||||||||||||||
|
b) |
Initial notification/Amendment |
Initial Notification |
||||||||||||||||||||||||||||||
|
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||||||||||||||||||||||||
|
a) |
Name |
Elixirr International plc |
||||||||||||||||||||||||||||||
|
b) |
LEI |
213800MKY7OHMVAKW681 |
||||||||||||||||||||||||||||||
|
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||||||||||||||||||||||||
|
a) |
Description of the Financial instrument, type of instrument |
Ordinary shares of 0.005p each ("Ordinary Shares") |
||||||||||||||||||||||||||||||
|
Identification code |
GB00BLPHTX84 |
|||||||||||||||||||||||||||||||
|
b) |
Nature of the transaction |
Sale of Ordinary Shares |
||||||||||||||||||||||||||||||
|
c) |
Price(s) and volume(s) |
|
||||||||||||||||||||||||||||||
|
d) |
Aggregated information: · Aggregated volume · Price |
As in 4c) above |
||||||||||||||||||||||||||||||
|
e) |
Date of the transaction |
8 July 2024 |
||||||||||||||||||||||||||||||
|
f) |
Place of the transaction |
Off market transaction |
||||||||||||||||||||||||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
